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Summary
Full activity of fibroblast growth factors (FGFs) requires
their internalization in addition to the interaction with cell
surface receptors. Recent studies have suggested that the
transmembrane proteoglycan syndecan-4 functions as a
FGF2 receptor. In this study we investigated the molecular
basis of syndecan endocytosis and its role in FGF2
internalization in endothelial cells. We found that
syndecan-4 uptake, induced either by treatment with FGF2
or by antibody clustering, requires the integrity of plasma
membrane lipid rafts for its initiation, occurs in a nonclathrin-, non-dynamin-dependent manner and involves
Rac1, which is activated by syndecan-4 clustering. FGF2

Key words: Rac1, Macropinocytosis, Heparan sulfate, Growth
factors, Signaling

Introduction
Fibroblast growth factors (FGFs) play a multitude of roles in
modulation of cell growth, migration and differentiation
(Ornitz and Itoh, 2001). The signaling activity of FGFs
involves interaction with high affinity tyrosine kinase receptors
and cell surface heparan sulfates. The latter molecules have
long been thought to play a role as co-receptors for heparin
binding growth factors such as FGFs. In particular, studies of
FGF2 signaling established its dependence on the presence of
cell surface heparan sulfates (Rapraeger et al., 1994) that are
carried on membrane-bound core proteins, syndecans and
glypicans (Rosenberg et al., 1997; Zimmermann and David,
1999). However, more recent studies have suggested that some
core proteins themselves, and not just their heparan sulfate
chains, may play an important role in signal transduction. Of
these, syndecan-4 has emerged as a signaling receptor because
of its ability to bind and activate protein kinase C α (PKCα)
upon FGF2-induced oligomerization (Simons and Horowitz,
2001). This association of syndecan-4 with PKCα puts the
proteoglycan in a category similar to other transmembrane
receptors, such as integrins, that do not possess intrinsic
catalytic activity, but are associated with kinases or
phosphatases.
A substantial body of literature suggests that full activity of
FGFs requires not only receptor interactions but also their
internalization (Goldfarb, 2001) and that the latter may proceed
via heparan sulfate proteoglycans-dependent and -independent
pathways (Citores et al., 1999; Gleizes et al., 1995; Grieb and

Burgess, 2000; Roghani and Moscatelli, 1992). Internalization
of trans-membrane proteins plays an important role in multiple
cellular processes. In particular, syndecan endocytosis has been
suggested as an important regulator of lipoprotein uptake (Fuki
et al., 1997; Williams, 2001). At the same time, the details of
FGF endocytosis and the involvement of specific proteoglycans
have not been established.
Recent studies demonstrating direct syndecan-4 involvement
in FGF2 signaling (Horowitz et al., 2002; Volk et al., 1999)
raise the possibility that this proteoglycan may also play a role
in its internalization thereby providing an additional avenue for
regulation of its activity. This possibility is bolstered by
observations that syndecan-4 binding to soluble (e.g. growth
factors) or extracellular matrix ligand or cell exposure to
mechanical stress results in its endocytosis (Li and Chaikof,
2002; Tkachenko and Simons, 2002). However, the link
between syndecan-4 endocytosis and FGF2 internalization as
well as molecular mechanisms of this process have not been
defined.
To gain further insight into syndecan-4 function, we studied
its clustering-induced endocytosis in endothelial cells. We find
that following oligomerization, the core protein is internalized
from the plasma membrane in a lipid raft-dependent, clathrinand dynamin-independent manner by a process that is amiloride
sensitive and requires activation of the small GTPase Rac1.
Furthermore, syndecan-4 clustering induced by FGF2 resulted
in FGF2 internalization together with syndecan-4 and 70 kDa
dextran in the same endocytic vesicles. FGF2 and syndecan-4

was internalized in a complex with syndecan-4 in 70 kDa
dextran-containing endocytic vesicles. FGF2 and syndecan4 but not dextran endocytosis were blocked by the
dominant negative Rac1 while amiloride and the dominantnegative Cdc42 blocked internalization of dextran in
addition to FGF2 and syndecan-4. Taken together, these
results demonstrate that FGF2 endocytosis requires
syndecan-4 clustering-dependent activation of Rac1 and
the intact CDC42-dependent macropinocytic pathway.
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but not dextran internalization was blocked by dominant
negative Rac1, while amiloride and dominant-negative Cdc42
blocked internalization of not only FGF2 and syndecan-4 but
also of 70 kDa dextran. This set of conditions shows that FGF2induced syndecan-4 clustering leads to internalization of both
proteins that proceeds via a macropinocytic pathway. Activation
of Rac1 is required for the initiation of syndecan-4 endocytosis
that also requires a fully functional macropinocytic pathway.
Materials and Methods
Antibodies and reagents
Human non-immune IgG and F(ab′)2 fragment-specific goat antihuman Igb F(ab′)2 antibodies were purchased from Jackson
Immunoresearch Laboratories (West Grove, PA, USA). Alexa-488
and Alexa-647 labeling kits, anti-HA epitope antibodies directly
labeled by Alexa-488 and Zenon Alexa Fluor-488 mouse IgG1
labeling kit, BODIPY® FL C5-ganglioside GM1 complexed to bovine
serum albumin (BSA) and dextran-rhodamineB 70 MW were
purchased from Molecular Probes. Alexa-488-conjugated inactive
variant of the protein proaerolysin (FLAER) was purchased from
Protox Biotech (Victoria, British Columbia, Canada). Mouse anti-cmyc epitope-tagged monoclonal antibody (mAb) was purchased from
Sigma. Chicken IgY anti-extracellular domain of syndecan-4 was
fluorescently labeled with Alexa-488 according to the manufacturer’s
protocol (Molecular Probes). Human recombinant FGF2 was courtesy
of Chiron Corporation (Sunnyvale, CA, USA). All other reagents
were purchased from Sigma.
cDNA constructs and transfections
Fc receptor-syndecan-4 chimera (FcR-S4) construct was previously
described (Tkachenko and Simons, 2002), eGFP-Cdc42-N17 (dominant
negative), eGFP-Cdc42-I61(constitutively active), eGFP-Rac1b-N17
(dominant negative), eGFP-Rac1b-I61(constitutively positive) and GPIGFP plasmids were provided by M. Way (Cancer Research UK) and S.
Mayor (Sabharanjak et al., 2002) (National Centre for Biological
Sciences, Bangalore, India). RhoA T19N (dominant negative) and RhoA
G14V (constitutively active) were purchased from Guthrie Research
Institute and were recloned into pIRES2-eGFP bicistronic vector
(Clontech, CA, USA). eGFP-clathrin light chain construct was a kind
gift from J. Keen (Thomas Jefferson University, Philadelphia, PA, USA),
AP180C was from H. McMahon, dynamin1K44A from S. Schmid
(Scripps Research Institute, La Jolla, CA, USA) and dynamin2k44a
construct was from M. A. McNiven (Cao et al., 1998). Rat fat pad
endothelial cells (RFPEC) were cultured in DMEM (Invitrogen, CA,
USA) as described previously (Horowitz et al., 2002).
Endocytosis assays
To label vesicles that undergo macropinocytosis, rat fat pad
endothelial cells (RFPEC) were incubated on ice in 1% BSA-DMEM
for 30 minutes. Neutral 70-kDa Dextran (rDx)-Rhodamine B was
added to a final concentration of 0.5 mg/ml and incubated with cells
at 37°C in 5% CO2 for 20 minutes. To label clathrin-coated endocytic
vesicles cells were incubated in 1% BSA-DMEM and then loaded
with 1 µg/ml of DiI-LDL or 25 µg/ml of transferrin-Alexa647 (TfR)
followed by incubation for 30 minutes on ice, washed once and then
incubated at 37°C for 20 minutes in 5% CO2. Labeling of endogenous
GPI-anchored proteins by FLAER was done as previously described
(Tkachenko and Simons, 2002).
FGF2 labeling with Alexa Fluor 647
In order to protect the syndecan-4 binding sites, FGF2 (1 mg) was
adsorbed to 0.5 ml bed-volume heparin-Sepharose beads (Amersham

Biosciences). The beads were washed with ice-cold 0.1 M NaHCO3,
re-suspended in 1 ml of ice-cold 0.1 M NaHCO3, pH 8.2.
AlexaFluor647 succinimidyl ester was added (0.5 mg in 0.2 ml 0.1 M
NaHCO3) and the mixture was shaken for 1 hour at 4°C. The
supernatant was drained and the column washed with 4 ml TBS and
2 ml 10 mM Tris/0.3 M NaCl pH 7.5. Labeled FGF2 was eluted with
2 ml 10 mM Tris/2 M NaCl pH 7.5 and desalted using two Hi-Trap
desalting cartridges connected in series and elution with Tris-buffered
saline. The FGF2-containing fraction was concentrated in an Amicon
10-kDa centrifugal filter (Millipore) and protein concentration was
determined by spectrophotometry. The labeling ratio dye:FGF2 was
0.5:1, which was intended to be low as not to interfere with the
biological function of FGF2.
Syndecan clustering
Antibody and FGF2 clustering were performed as described
previously (Tkachenko and Simons, 2002). Briefly, RFPEC stably
expressing FcR-syndecan-4 were plated and grown overnight in 10%
FBS-DMEM. For antibody clustering, cells were washed with DMEM
and incubated in the presence of biotinylated non-immune IgG (1
µg/ml) for 15 minutes in DMEM supplemented with 1% BSA at 37°C.
Then cells were washed with ice-cold DMEM and incubated for
another 30 minutes on ice with anti-human F(ab′)2-Cy3 (3 µg/ml) in
DMEM-1% BSA followed by wash as above and incubation at 37°C
with 5% CO2 in DMEM 1% BSA for various times. To distinguish
plasma membrane syndecan-4 from internalized syndecan-4, the cells
were then washed with ice cold medium and incubated with
steptavidin-Cy5 or streptavidin-Alexa488 (1:400 dilution) for 30
minutes at 4°C. At this temperature, streptavidin has access only to
the surface bound biotinylated IgG, or the IgG that is in vesicles open
to the cell surface. For FGF2 labeling, cells were washed with icecold DMEM twice and incubated for 30 minutes on ice in DMEM in
the presence of 50 ng/ml of FGF2-Alexa Fluor. After washing cells
were incubated in DMEM-1% BSA for various times. To remove
remaining cell surface FGF2, cells were place on ice and incubated
with 10 mg/ml of heparin in DMEM.
Immunofluorescence microscopy
RFPEC were plated in chamber slides (Nalge Nunc), fixed with 2%
paraformaldehyde for 10 minutes at room temperature, then washed
twice with phosphate-buffered saline (PBS), permeabilized with 0.1%
Triton X-100/PBS for 10 minutes, washed again as above, blocked with
3% BSA/PBS for 30 minutes, and incubated with primary antibodies
(1 µg/ml) in 1% BSA/PBS overnight at 4°C. The slides were then
washed four times as above, and incubated for 1 hour with 10 µg/ml of
the appropriate reporter-conjugated secondary antibodies, washed again
as before, and mounted with ProLong medium (Molecular Probes).
Fluorescence microscopy was carried out on live cells as described
previously (Tkachenko and Simons, 2002). Imaging was carried out
using Bio-Rad MRC-1024 and Ziess LSM 510 Meta laser confocal
system microscopes with Zeiss 63× objectives. Image analysis was done
using Adobe Photoshop 7.0 (Adobe Systems Inc.), AutoDeblur 9.1
(Auto Quant Imaging Inc.) and Image J software (NIH).
Toxin treatment and plasma membrane cholesterol depletion
RFPEC were incubated with 20 ng/ml of Clostridium difficile toxin
B for 3 hours or 100 ng/ml exotransferase C3 for 12-16 hours in the
normal growth medium. 5-(N-ethyl-N-isopropyl) amiloride treatment
of RFPEC was performed as described previously (Muro et al., 2003).
Plasma membrane cholesterol depletion was accomplished by
pretreatment of cultured cells with 10 mM methyl β-cyclodextrin
(MβCD), for 30 minutes at 37°C followed by a wash with DMEM
and standard clustering procedure. MβCD removes unesterefied
cholesterol from the cell membrane (Rodrigueza et al., 1997).

Syndecan-4 endocytosis
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Fig. 1. Internalization of the
native and chimera syndecan-4
proteins. (A) RFPEC cells
expressing the FcR-S4 construct
were decorated with Cy3labeled (red) human nonimmune IgG (niIgG) and then
clustered with AlexaFluor 647labeled (green) FGF2. IgG
decorated FcR-S4 chimeras are
present on the surface of the
cells and in the cytoplasm 20
minutes after FGF2 clustering
(red). FGF2 is present both on
the cell surface and in the
cytoplasm. Note co-localization
(yellow) of internalized FGF2
and FcR-S4 chimeras (merged
image). This observation is
consistent with FGF2-induced
oligomerization of FcR-S4
native S4 heterodimers.
(B) FcR-S4-expressing cells
decorated with biotinylated
niIgG followed by clustering
with Cy3-labeled clustering
antibodies (red). Biotinylated niIgG remaining on the cell surface was visualized by streptavidin-Cy5 (green). Dual stain on the merged image
shows cell surface localized FcR-S4 whereas single red stain shows internalized FcR-S4. Right figure shows the merged color image overlaid
with a DIC image. Lower figure shows Z-plane projection of the area in the white rectangle.
Quantitative measurements of endocytic uptake
Endocytic uptake of dextran, transferrin, GPI-GFP, GM1-BODIPY,
FcR-syndecan 4 and FGF2 was quantified as previously described
(Sabharanjak et al., 2002). In brief, 10-15 images were acquired from
two wells of the same experiment and the number of cells showing
high level of uptake relative to untransfected cells was scored. The
data are presented as mean of three or four independent experiments,
each with 20 or more cells.
In addition, the effect of various toxin treatments on syndecan-4
and transferrin uptake was measured by flow cytometry. For these
experiments (n=3) cells were grown to ~70-80% confluence on 24well plates. Toxin treatments, FcR-syndecan 4 and transferrin uptake
assays were performed as described above. At the end of the
experiment plates were placed on ice, washed once with ice-cold PBS
pH 7.4 and then twice with ice-cold acidic PBS pH 2.5 for 30 seconds
to remove cell-surface bound fluorescent ligands (Fuki et al., 2000).
Cells were then trypsinized, washed once with PBS pH 7.4 and
resuspended in DPBS pH 7.4 with 1% BSA. Flow cytometry was
performed and analyzed as previously described (Tkachenko and
Simons, 2002).
Rho GTPase pulldown assays
To determine activation of Rho, Rac and Cdc42 after FcR-S4
clustering, EZ-detect Rho and Rac1 activation kits (Pierce) were used.
In brief, cells were seeded on fibronectin-coated 100 mm dishes and
grown to 80% confluency then starved for 24 hours in DMED 0.5%
FBS. Following antibody clustering performed as described above,
cells were lysed in 250 µl lysis/binding/washing buffer including
proteinase inhibitors (Pierce). As positive and negative controls, four
clarified non-clustered cell lysates (500 µg) were treated with either
0.1 mM GTPγS or 1.0 mM GDP in the presence of 10 mM EDTA,
pH 8.0 at 30°C for either 15 minutes (to activate or inactivate Rac1
and Cdc42) or 30 minutes (to activate or inactivate Rho). The
nucleotide exchange reaction was terminated by adding MgCl2 and
placing samples on ice.

The cell lysates (500 µg) were then incubated with either GST-Pak1PBD (to pull down active Cdc42 or Rac1) or GST-Rhotekin-RBD (to
pull down active Rho) in the presence of SwellGel-immobilized
glutathione at 4°C for 1 hour in a spin column. After incubation, the
mixture was centrifuged at 8,000 g to remove the unbound proteins.
The resins were washed three times with lysis/binding/wash buffer and
the sample was eluted by adding 50 µl of 2× SDS sample buffer and
boiling at 95°C for 5 minutes. Half (25 µl) of the sample volumes were
analyzed by SDS-PAGE and transferred to a PDVF membrane. The
active Rac1 and Rho were detected by western blotting using a specific
mouse monoclonal antibody. A goat anti-mouse antibody conjugated
with HRP was used as the secondary antibody. For the detection of
Cdc42, anti-Cdc42 monoclonal antibody (Upstate) was labeled using
the Zenon Alexa-488 mouse IgG1 labeling kit and applied to the
rac1/cdc42 PVDF membrane. Detection was performed using West
Pico Chemiluminescent Substrate (Rho and Rac1) (Pierce) or
fluorometry (Cdc42) followed by exposure to X-ray film or detection
of fluorescence in a Typhoon 9410 (Amersham Biosciences) detector,
respectively.

Results
Clustering initiates syndecan-4 endocytosis
To study plasma membrane syndecan-4 internalization, we
used live confocal laser microscopy to track the core protein
in endothelial cells before and after FGF2 and/or antibodyinduced clustering. To help visualize the fate of the native
syndecan-4, we took advantage of heterodimerization between
the wild-type syndecan-4 and the FcR-S4 chimeras previously
demonstrated in the FcR-S4-expressing RFPEC (Tkachenko
and Simons, 2002). In quiescent endothelial cells both the FcRS4 chimera and the wild-type syndecan-4 were similarly
expressed on the plasma membrane (Fig. 1A). FcR-S4expressing RFPEC were treated with Cy3-labeled IgG. This
decorates chimeras expressed on the cell plasma membranes
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Fig. 2. Syndecan-4 is internalized from lipid raft
regions of the plasma membrane. Confocal
microscopy of syndecan-4 endocytosis was
carried out in RFPEC expressing the FcR-S4
chimera. The raft portion of the plasma
membrane was labeled with BODIPY GM1
(blue) (a) or by transient expression of GPI-GFP
construct (f). FcR-S4 chimeras were decorated
with biotinylated niIgG and clustering was then
initiated by the addition of Cy3-F(ab′)2
fragments (red). Five minutes after the initiation
of antibody clustering, all internalized FcR-S4
chimeras (b) were seen in close association with
GM1-BODIPY (magenta, a,d,c) membrane
domains or with GPI-GFP (yellow, h and i).
(e,i) Merged color images (d and h, respectively)
overlaid with DIC images. The depletion of
membrane cholesterol with MβCD fully blocks
clustering-induced FcR-S4 internalization
(j,k,l,m). Scale bars, 10 µm.

but does not initiate their internalization (not shown). The cells
were then treated with FGF2. Twenty minutes after FGF2
exposure, there was a substantial internalization of FcR-S4
chimeras (Fig. 1A, left panel) and of FGF2 itself (Fig. 1A,
middle panel). The merged image demonstrates significant
intracellular co-localization of FGF2 and FcR-S4 signals (Fig.
1A, right panel). This suggests that FcR-S4 chimeras that have
formed heterodimers with the native syndecan-4 core protein,
were internalized when the latter was oligomerized by the
FGF2 treatment, as we have shown previously (Tkachenko and
Simons, 2002).
Similarly, F(ab′)2-mediated clustering of IgG-decorated

FcR-S4 chimeras also induced their internalization (Fig. 1B).
Overall, kinetics of FcR-S4 chimera endocytosis was similar
to that of the endogenous syndecan-4 with 50% of both
proteins internalized within 20 minutes of antibody-mediated
clustering.
Syndecan-4 endocytosis depends on the integrity of the
lipid rafts and occurs in a clathrin and dynaminindependent manner
We have previously shown that FGF2-induced syndecan-4 or
antibody-induced FcR-S4 chimera oligomerization result in
redistribution of approximately 50% of the
total plasma membrane content of these
proteins to the lipid rafts (Tkachenko and
Simons, 2002). To determine whether
syndecan-4 endocytosis proceeds from the
rafts or a non-raft portion of the plasma
membrane, we used confocal microscopy of

Fig. 3. Syndecan-4 is internalized with
endogenous GPI-anchored proteins. (a) FcR-S4
expressing RFPES were labeled with FLAER,
decorated by biotinylated niIgG and clustered by
Cy-3-F(ab′)2. (b) Five minutes after clustering,
cells were placed on ice and the cell surface FcRS4 was detected with streptavidin-Cy5.
(c) FLAER-labeled GPI-anchored proteins.
(d-f) Cell surface (d,f) and internalized (e,f) FcRS4 demonstrate high level of colocalization with
GPI-anchored proteins. Arrows in f point to
examples of FcR-S4- and FLAER-labeled
internalized vesicles. Scale bars, 10 µm.

Syndecan-4 endocytosis
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Fig. 4. Syndecan-4 is internalized in the clathrin- and dynamin-independent manner. (a-c) Syndecan-4 endocytosis was studied in FcR-S4
expressing RFPEC transiently transfected with various constructs. Antibody clustering of FcR-S4 chimeras carried out as described in Fig. 1
and 2 leads to internalization of syndecan-4 (a). Note the absence of co-localization of internalized syndecan-4 with clathrin in cells expressing
clathrin-eGFP 5 minutes after clustering (b,c). The effect of clathrin dominant negative was studied in cells transiently expressing a c-myc
tagged AP180C construct (d). Cell expressing AP180C demonstrates the same FcR-S4 internalization as non-transfected cells (e,f,g,h). The
FcR-S4 remaining on the cell surface is shown in green and internalized FcR-S4 is in red. (i-m) The role of dynamin was studied in cells
transiently expressing a dominant-negative HA-tagged dyn2K44A construct (i). Note that the cell expressing Dyn2K44A demonstrates high level
of FcR-S4 internalization (r,i,l,m). h and m show the color images in g and l, merged with their respective DIC images. In g, h and i internalized
FcR-S4 is in red, and in f,g,h,k,i FcR-S4 constructs remaining on the cell surface are in yellow and green. Scale bars, 10 µm.

live cells to track internalized FcR-S4 chimeras as well as
BODIPY-GM1, a lipid raft marker.
Within 5 minutes after clustering with F(ab′)2 fragments,
most if not all internalized FcR-S4 chimeras co-localized with
BODIPY-GM1 (Fig. 2a-e). To confirm this finding, we
examined syndecan-4 endocytosis in RFPEC-expressing GPIanchored GFP. Following antibody clustering of the FcR-S4
chimera, confocal microscopy of live cells demonstrated
considerable co-localization between the internalized
syndecan-4 chimeras and GPI-GFP (Fig. 2f-i). To confirm colocalization of internalized syndecan-4 with rafts proteins, we
used FLAER to detect GPI-anchored proteins (Brodsky et al.,
2000; Tkachenko and Simons, 2002). As in the GPI-GFP
studies, we observed a high level of colocalization of
internalized syndecan-4 with FLAER-labeled endogenous
GPI-anchored proteins (Fig. 3). These results suggest,
therefore, that essentially all internalized syndecan-4
originated from a region rich in lipid rafts. To confirm this
conclusion, we used methyl β-cyclodextrin (MβCD) to deplete
plasma membrane cholesterol content thereby preventing
formation of lipid rafts. As expected, MβCD treatment
completely prevented antibody-induced internalization of FcRS4 chimeras (Fig. 2j-m).
Internalization of plasma membrane receptors can occur via
clathrin-dependent or independent pathways. To determine the

role played by clathrin in syndecan-4 internalization, we
examined co-localization of the endocytosed syndecan-4 and
clathrin-LC-eGFP and studied the effect of expression of the
AP180C construct that has been shown to selectively block
clathrin-dependent endocytosis (Ford et al., 2001) on
syndecan-4 uptake. Confocal microscopy demonstrated no colocalization between syndecan-4 and clathrin (Fig. 4a-c). After
transient transfection of AP180C into RFPEC, cells
demonstrating AP180C expression showed, as expected,
inhibition of clathrin-dependent transferrin uptake (a).
Syndecan-4 endocytosis, however, was not affected by
AP180C expression (Fig. 4d-h, Fig. 5a). These results suggest
that syndecan-4 endocytosis occurs via a clathrin-independent
pathway.
To further define the endosomal pathway involved in
syndecan-4 trafficking, dynamin dominant-negative constructs
specific for both dynamins, dyn1K44A and dyn2K44A were
transiently expressed in RFPEC. While expression of either
dynamin construct had little effect on syndecan-4 endocytosis
(Fig. 4i-l, Fig. 5a), both dynamin dominant negatives inhibited
clathrin-dependent transferrin uptake (Fig. 5a).
Syndecan-4 endocytosis requires Rac1
Rho GTPases are involved in a number of endocytic processes.
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Fig. 6. Rac1 activation by syndecan-4 clustering. Time course of
Rac1, RhoA and Cdc42 activation following antibody
oligomerization of FcR-S4 chimeras. GST pull down assays with
specific substrates were performed as described in the Materials and
Methods. Note activation of Rac1 5 minutes after initiation of
syndecan-4 oligomerization while neither RhoA nor Cdc42 activity
is changed.

Cd c4 2- D N

C dc4 2 - CA

Amiloride

Fig. 5. Quantitative analysis of syndecan-4 endocytosis was carried
out using confocal microscopy as described in the Materials and
Methods. The results are presented as a fold change from baseline
for each substance. (A) The effects of dominant negative constructs
(AP180c) and dynamins 1 and 2 (Dyn1K44A and Dyn2K44A) on
clathrin-dependent uptake of syndecan-4 (black bars) and transferrin
(gray bars). Note inhibition of transferrin but not syndecan-4 uptake.
* P<0.05 versus baseline. (B) The effects of Rac1 and Cdc42
dominant negative and constitutively active constructs and amiloride
treatment on FcR-syndecan-4 (black bars), FGF2 (gray bars) and
dextran (white bars) uptake was examined in RFPEC. Note a
significant inhibition of syndecan-4 and FGF2 uptake in Rac1-DNexpressing cells and increased uptake in Rac1-CA expressing cells.
Cdc42-DN and amiloride inhibited uptake of all three substances.
*P<0.05 versus baseline endocytosis.

To examine the involvement of these GTPases in
oligomerization-induced syndecan-4 uptake, we first studied
the effect of syndecan oligomerization on activation of
different Rho family members. To this end, we examined the
time course of activation of RhoA, Cdc42 and Rac1 in RFPEC
expressing the FcR-S4 construct following antibody-induced
chimera oligomerization. While there was no change in RhoA
or Cdc42 activity, within 5 minutes there was a significant
activation of Rac1 that gradually declined to baseline levels
over the next 60 minutes (Fig. 6).
Since Rac1 activation preceded the activation of syndecan4 endocytosis and reverted to baseline levels when its
endocytosis was complete, we next examined whether Rac1
activation is indeed required for this process. Treatment of
cells with C. difficile toxin B, inhibitor of all Rho GTPases,
completely abolished all FcR-S4 endocytosis (Fig. 7a). At the
same time, treatment with a RhoA inhibitor, C3
exotransferase, had no effect on this process (Fig. 7b). To
further investigate which Rho family member is involved in
syndecan endocytosis, dominant negative Rac1 and RhoA as
well as constitutively active mutants of Rac1, Cdc42 and

RhoA were transiently expressed in RFPEC expressing FcRS4 chimeras and their effect on clustering-induced syndecan4 endocytosis was then examined. Transient expression of a
Rac1DN construct completely blocked FcR-S4 endocytosis
while the expression of a Rac1 constitutively active construct
markedly accelerated it (Fig. 8a, Fig. 5b). Transient
expression of a Cdc42 dominant also downregulated
syndecan-4 endocytosis while a Cdc42 constitutively active
construct had no effect (Fig. 8b, Fig. 5b). At the same time,
expression of RhoA dominant negative or constitutively
active constructs had no effect on FcR-S4 internalization
(Fig. 8c, Fig. 5b).
Syndecan-4 and FGF2 internalization proceeds via
macropinocytosis
The involvement of Rac1 in syndecan-4 endocytosis suggests
that the latter might proceed via a macropinocytic pathway. To
evaluate this possibility FcR-S4-expressing RFPEC were
treated with fluorescently labeled 70 kDa dextran and then
syndecan clustering was induced by an antibody or by addition
of fluorescently labeled FGF2 (Fig. 9a-c). Confocal
microscopy of live cells demonstrated partial co-localization of
internalized dextran and FcR-S4 (Fig. 9d) following antibody
clustering, a finding consistent with the presence of FcR-S4
chimera in macropinocytic vesicles. Similarly, following FGF2
treatment of endothelial cells exposed to dextran, there was
considerable co-localization of dextran and FGF2 signals (Fig.
9e) and both FGF2 and dextran were observed in syndecan-4containing vesicles (Fig. 9f).
Since macropinocytosis is sensitive to amiloride, we
examined the effect of this inhibitor on both syndecan-4 and
FGF2 endocytosis. Pretreatment of cells with amiloride
completely inhibited internalization of dextran, as expected
(Fig. 5b). At the same time, it also inhibited both the antibody
clustering-induced FcR-S4 chimera endocytosis (Fig. 9g-j) and
FGF2 endocytosis (not shown, see Fig. 5b for quantification).
However, amiloride did not inhibit uptake of GM1 and GPIGFP (not shown).
Since modulation of Rac1 activity affected syndecan-4
endocytosis, we examined its effect on FGF2 uptake as well as
macropinocytosis as defined by dextran internalization.
Transient expression of a dominant negative Rac1 construct
significantly inhibited FGF2 endocytosis while a constitutively
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Fig. 7. Role of Rho family GTPases in
syndecan-4 endocytosis. The effect of
pre-treatment with C. difficile toxin B
(A) and C3 exotransferase (B) on
syndecan-4 endocytosis was examined
in antibody-clustered FcR-S4
chimeras. Note that while toxin B
treatment completely inhibited FcR-S4
endocytosis, C3 exotransferase had no
effect. Scale bars, 10 µm.

active Rac1 increased it (Fig. 10a,b). At the same time neither
construct affected dextran uptake (Fig. 5b).
To contrast effects of membrane cholesterol depletion and
amiloride and clathrin-dependent uptake of transferrin and
clathrin-independent endocytosis of syndecan-4 and to
corroborate confocal microscopy data, we used flow cytometry
to quantitate these processes. In agreement with the confocal
microscopy results, cyclodextrin treatment virtually
completely inhibited syndecan-4 uptake while reducing
transferrin endocytosis to a lesser degree (Fig. 11). This is
consistent with similar published results (Rodal et al., 1999;
Subtil et al., 1999). However, the possibility of a yet undefined
effect of cyclodextrin on macropinocytosis cannot be excluded.
Amiloride also fully inhibited syndecan-4 uptake as expected
for a macropinocytic process, while mildly stimulating
transferrin entry into cells (Fig. 11).
Finally, to explore whether syndecan-4 clustering affects the
rate of macropinocytosis, we measured dextran uptake
following antibody clustering of FcR-S4 chimeras, native
syndecan-4 or following FGF2 treatment. In all cases, dextran
uptake was not affected (not shown) suggesting that syndecan4 clustering or FGF2 treatment does not stimulate
macropinocytosis.
Discussion
The results of this study demonstrate that FGF2 internalization
proceeds in a syndecan-4-dependent manner and document the
endocytic pathway of syndecan-4 uptake. The pathway is
initiated by the cell plasma membrane syndecan-4 clustering
that results in Rac1 activation and proceeds in a caveolae-,
clathrin- and dynamin-independent manner. Moreover, it is
amiloride and Cdc42 sensitive and results in dextran and FGF2
internalization in the syndecan-4-containing vesicles. These
data are consistent with the notion that syndecan-4 clustering
initiates its endocytosis via activation of Rac1 that allows

syndecan-4 to detach from the actin cytoskeleton, enter the
macropinocytic pathway and to internalize FGF2.
Receptor endocytosis can proceed in a clathrin-dependent
and -independent manner (Conner and Schmid, 2003). While
endocytosis of most receptors, including G protein-coupled
(Pierce et al., 2000) and tyrosine kinase receptors (Vieira et al.,
1996) was originally described as clathrin-dependent, recent
studies have clearly shown that clathrin-independent receptor
endocytosis plays an equally important role (Nichols and
Lippincott-Schwartz, 2001). To date a number of different
clathrin-independent internalization pathways have been
described that typically involve GTPase dynamin, different
Rho GTPases and either caveolae or non-caveolar lipid raft
portion of the plasma cell membrane. One such pathway is the
internalization of interleukin-2 receptor from the plasma
membrane rafts. The process is rapid and requires the GTPase
dynamin and a small GTPase RhoA in an activated state
(Lamaze et al., 2001). The latter observation is in marked
contrast to the clathrin-mediated endocytosis where RhoA and
Rac1 act as negative regulators.
An example of another pathway is folate uptake via its
receptor, a GPI-anchored protein, that is accomplished in a
clathrin, dynamin- and caveolae-independent manner and is
regulated by Cdc42 (Sabharanjak et al., 2002). This pathway
bears considerable similarity to FGF2/syndecan-4 endocytosis
including its origin from the plasma membrane rafts, lack of
dependence on dynamin and clathrin and inhibition by a Cdc42
dominant negative.
The major difference between the two processes arises from
FGF2/syndecan-4 uptake dependence on activation of Rac1
that has not been reported by the folate/GPI protein
endocytosis. The involvement of Rac1 in a non-clathrindependent endocytosis has previously been described but it has
been limited to fluid phase pinocytosis that seems also to
involve Pak1 (Dharmawardhane et al., 2000). Rac1 is also
involved in type 1 phagocytosis where it acts in conjunction
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Fig. 8. Specific role of Rho GTPases in syndecan-4 endocytosis. The contributions of Rac1, Cdc42 and RhoA GTPases to syndecan-4
endocytosis were studied in FcR-S4-expressing RFPEC transiently transfected with eGFP-tagged dominant negative and constitutively active
constructs. (A) A dominant negative Rac1 completely inhibited (left panels) while a constitutively active Rac1 stimulated (right panels) FcR-S4
endocytosis. (B) The expression of a dominant negative Cdc42 construct (left) somewhat inhibited FcR-S4 endocytosis while a constitutively
active (right) Cdc42 constructs had no effect. (C) The expression of dominant negative (left) or constitutively active (right) RhoA constructs had
no effect on FcR-S4 endocytosis. CA, constitutively active; DN, dominant negative. Scale bars, 10 µm.

Fig. 9. Syndecan-4 and FGF2 uptake proceed via
macropinocytosis. FcR-S4-expressing RFPEC
cultured with fluorescent dextran (red, a) were
decorated by niIgG (green, b) followed by FGF2
(blue, c) clustering. Merged images demonstrate colocalization of dextran and syndecan-4 (d), dextran
and FGF2 (e) and all three signals (f). Amiloride pretreatment completely inhibited endocytosis of both
dextran (g) and FcR-S4 (h-j). (k) The merged image
overlaid with the DIC image. Scale bars, 10 µm.
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Fig. 10. Rac1 regulates FGF2
endocytosis. The effect of
transient expression of Rac1
dominant negative (Rac1 DNeGFP, A) and constitutively
active (Rac1 CA-eGFP, B)
constructs on FGF2 endocytosis
was examined in RFPEC
treated with fluorescently
labeled FGF2 (red). Note
decreased FGF2 uptake in cells
expressing Rac1 DN-eGFP and
increased uptake in cells
expressing Rac1 CA-eGFP.
Scale bars, 10 µm.
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Fig. 11. Flow cytometry analysis of syndecan-4 endocytosis. The
effects of membrane cholesterol depletion by treatment with methylβ-cyclodextrin (MβCD) and amiloride on uptake of transferrin and
FcR-syndecan-4 were analyzed using flow cytometry as described in
the Materials and Methods. The data are presented as fold change
from baseline. MβCD treatment almost fully blocked syndecan
uptake while significantly reducing the level of transferrin
internalization. Amiloride treatment inhibited syndecan uptake but
increased the rate of transferrin endocytosis. *P<0.05 versus
baseline.

with Cdc42 (Ellis and Mellor, 2000). However, Rac1 function
is very complex as shown by studies in epithelial cells where
expression of the dominant negative Rac1 decreased the rates
of apical and basolateral endocytosis and inhibited apical
recycling of IgA whereas the constitutive active Rac1 mutant
had the opposite effect (Jou et al., 2000)
In the case of syndecan-4, Rac1 activation is required for its
endocytosis while the activity of RhoA does not affect this
process. This conclusion is supported by several observations.
First, is the observation that a pan-Rho GTPase inhibitor, C.
difficile toxin B, inhibited all syndecan-4 uptake while a RhoA
specific inhibitor, C3 exotransferase, had no detectable effect
on its endocytosis. Second, a dominant negative Rac1 mutant
completely inhibited syndecan-4 uptake while a constitutive
active Rac1 mutant markedly accelerated it. At the same time,

dominant negative and constitutive active forms of RhoA had
no effect on syndecan-4 endocytosis. Of note, the time course
of Rac1 activation by syndecan-4 oligomerization is in keeping
with its above described role in syndecan-4 uptake since its
activation precedes the initiation of the core protein
internalization and its activity returns to normal when the
process is complete. The capacity of syndecan-4 clustering to
activate Rac1 is in keeping with the known syndecan-4
oligomerization-dependent activation of PKCα (Horowitz and
Simons, 1998; Oh et al., 1997) and the ability of PKC agonist
PMA to activate Rac1 and to induce macropinocytosis
(Grimmer et al., 2002).
There are several possible explanations for the role of Rac1
in syndecan-4-dependent endocytosis. In quiescent cells plated
on fibronectin syndecan-4 participates in formation of focal
adhesions and is found in association with the actin
cytoskeleton (Saoncella et al., 1999). This linkage to actin may
involve recently described syndecan-4 binding to α-actinin
(Greene et al., 2003). Prior to clustering, syndecan-4 is absent
from the raft plasma membrane domain and it moves there in
response to FGF2 or antibody-induced oligomerization
(Tkachenko and Simons, 2002). This data is in agreement with
the finding that more than 50% of cell surface bound FGF2 is
found in lipid rafts (Chu et al., 2004). Such a movement
probably requires breaking of the syndecan-4-actin
cytoskeleton association, an event accomplished by Rac1
activation. Once translocated to the raft domain, syndecan-4
endocytosis proceeds in a manner similar to that of the folate
receptor. This is suggested by co-localization of syndecan-4
and BODIPY-GM1 and GPI-GFP markers of raft region
proteins and by the effect of dominant-negative CDC42. This
finding is also in agreement with a previously reported colocalization of syndecan-4 and the inactive variant of
proaerolysin, a marker of GPI-associated proteins (Tkachenko
and Simons, 2002).
The sensitivity of syndecan-4 uptake to inhibition with
amiloride and the presence of dextran in syndecan-4containing vesicles suggest that it proceeds via
macropinocytosis, a process that proceeds by formation of
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large endocytic vesicles brought about by the closure of
lamellopodia at ruffling membrane domains and is usually
thought of in the context of bulk fluid uptake. A recent study
demonstrated that dynamin 2 is required for PDGF-induced but
not constitutive macropinocytosis (Schlunck et al., 2004). This
finding suggests that there are at least two different
mechanisms of macropinocytic uptakes. This distinction is also
emphasized by the fact that while syndecan-4 is associated
with GM1 and GFP-GPI on the cells surface and in endosomes
they do not follow the same endocytic pathway.
It has been suggested that macropinocytosis may be involved
in internalization of large multimeric complexes and may play
a role, for example, in viral entry into cells (Liu et al., 2002;
Marechal et al., 2001) as well as endocytosis of several
endothelial plasma membrane proteins including ICAM-1,
PECAM-1 and E-cadherin (Muro et al., 2003; Paterson et al.,
2003). Finally, macropinocytosis is an attractive pathway for
syndecan internalization given the typical large sizes of its
heparan sulfate chains. This role of rafts in recruitment for
macropinocytosis may be similar to the recruitment of cholera
and anthrax toxins for uptake via the clathrin pathway (Abrami
et al., 2001; Shogomori and Futerman, 2001).
FGF2 internalization is an important consequence of
syndecan-4 endocytosis. In the cell type under study the
majority of FGF2 uptake occurred via the syndecan-4 pathway.
The dependence of FGF2 uptake on syndecan-4 endocytosis is
in keeping with previously published results that suggested that
both FGF1 and FGF2 enter cells via an endocytic process
involving heparan sulfate proteoglycans (Citores et al., 1999;
Gleizes et al., 1995; Roghani and Moscatelli, 1992). Such
proteoglycan-dependent uptake has been localized to uncoated
pits, in keeping with our finding of non-clathrin-dependent
uptake, and proceed at a relatively slow pace, once again
consistent with the kinetics of syndecan-4 internalization
observed in this study (Gleizes et al., 1995). The functional
significance of syndecan-4-dependent FGF2 internalization
has not been established but previous studies have suggested
that FGF1 uptake is required for its full mitogenic effect (Grieb
and Burgess, 2000).
In summary, we describe macropinocytosis of syndecan-4
triggered by its oligomerization on endothelial cell membranes
that results in internalization of the clustering agent, in this case
FGF2, and involves both Rac1 and Cdc42 GTPases. The
biological function of this pathway is the subject of future
studies.
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